{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=albuterol%2Fsalbutamol+90+mcg", "query": { "intervention": "albuterol/salbutamol 90 mcg" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 49, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=albuterol%2Fsalbutamol+90+mcg&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-07T11:27:47.840Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01844401", "title": "Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Albuterol Spiromax®", "type": "DRUG" }, { "name": "ProAir® HFA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 15, "start_date": "2013-04", "completion_date": "2013-10", "has_results": false, "last_update_posted_date": "2013-11-14", "last_synced_at": "2026-10-07T11:27:47.840Z", "location_count": 1, "location_summary": "Costa Mesa, California", "locations": [ { "city": "Costa Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01844401" }, { "nct_id": "NCT01174732", "title": "Dose-Ranging Study of A006 DPI, in Adult Asthma Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma", "Bronchospasm" ], "interventions": [ { "name": "albuterol inhalation powder", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "albuterol inhalation aerosol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amphastar Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 26, "start_date": "2010-07", "completion_date": "2011-01", "has_results": false, "last_update_posted_date": "2017-04-19", "last_synced_at": "2026-10-07T11:27:47.840Z", "location_count": 4, "location_summary": "San Jose, California • Centennial, Colorado • Denver, Colorado + 1 more", "locations": [ { "city": "San Jose", "state": "California" }, { "city": "Centennial", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" }, { "city": "Lakewood", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01174732" }, { "nct_id": "NCT02969408", "title": "A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Albuterol Sulfate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 397, "start_date": "2017-02-13", "completion_date": "2018-02-02", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-10-07T11:27:47.840Z", "location_count": 44, "location_summary": "Litchfield Park, Arizona • Bakersfield, California • Los Angeles, California + 37 more", "locations": [ { "city": "Litchfield Park", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Riverside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02969408" }, { "nct_id": "NCT01581177", "title": "Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Albuterol DPI 25 mcg/inh", "type": "DRUG" }, { "name": "Albuterol DPI 90 mcg/inh", "type": "DRUG" }, { "name": "Placebo DPI", "type": "DRUG" }, { "name": "Albuterol MDI 90 mcg/inh", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amphastar Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 23, "start_date": "2012-04", "completion_date": "2012-08", "has_results": false, "last_update_posted_date": "2017-05-19", "last_synced_at": "2026-10-07T11:27:47.840Z", "location_count": 4, "location_summary": "San Jose, California • Medford, Oregon • New Braunfels, Texas + 1 more", "locations": [ { "city": "San Jose", "state": "California" }, { "city": "Medford", "state": "Oregon" }, { "city": "New Braunfels", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01581177" }, { "nct_id": "NCT01747629", "title": "Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo MDPI", "type": "DRUG" }, { "name": "Albuterol MDPI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 160, "start_date": "2012-12", "completion_date": "2013-11", "has_results": true, "last_update_posted_date": "2015-06-26", "last_synced_at": "2026-10-07T11:27:47.840Z", "location_count": 35, "location_summary": "Costa Mesa, California • Encinitas, California • Huntington Beach, California + 30 more", "locations": [ { "city": "Costa Mesa", "state": "California" }, { "city": "Encinitas", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Palmdale", "state": "California" }, { "city": "Rancho Mirage", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01747629" }, { "nct_id": "NCT02584257", "title": "Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Mild Persistent Asthma" ], "interventions": [ { "name": "methacholine chloride", "type": "OTHER" }, { "name": "placebo ProAir HFA", "type": "DRUG" }, { "name": "ProAir HFA", "type": "DRUG" }, { "name": "Lupin albuterol HFA MDI", "type": "DRUG" }, { "name": "placebo Lupin albuterol HFA MDI", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Lupin, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 217, "start_date": "2016-04", "completion_date": "2016-09", "has_results": true, "last_update_posted_date": "2020-12-04", "last_synced_at": "2026-10-07T11:27:47.840Z", "location_count": 17, "location_summary": "Huntington Beach, California • Mission Viejo, California • Rolling Hills Estates, California + 14 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Jose", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02584257" }, { "nct_id": "NCT00706446", "title": "The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "tiotropium bromide", "type": "DRUG" }, { "name": "Salmeterol", "type": "DRUG" }, { "name": "Formoterol", "type": "DRUG" }, { "name": "Fluticasone propionate", "type": "DRUG" }, { "name": "budesonide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 255, "start_date": "2008-06", "completion_date": "2011-09", "has_results": true, "last_update_posted_date": "2017-05-31", "last_synced_at": "2026-10-07T11:27:47.840Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00706446" }, { "nct_id": "NCT01058863", "title": "A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Albuterol Spiromax®", "type": "DRUG" }, { "name": "ProAir® HFA", "type": "DRUG" }, { "name": "Placebo Inhaler", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 72, "start_date": "2010-02", "completion_date": "2010-06", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-10-07T11:27:47.840Z", "location_count": 13, "location_summary": "Huntington Beach, California • Rolling Hills Est., California • San Diego, California + 10 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Rolling Hills Est.", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Margate", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01058863" }, { "nct_id": "NCT03256695", "title": "Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Albuterol sulfate (ABS)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 405, "start_date": "2017-09-28", "completion_date": "2018-04-17", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-10-07T11:27:47.840Z", "location_count": 40, "location_summary": "Andalusia, Alabama • Anniston, Alabama • Mobile, Alabama + 34 more", "locations": [ { "city": "Andalusia", "state": "Alabama" }, { "city": "Anniston", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Gold River", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03256695" }, { "nct_id": "NCT01189396", "title": "Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma", "Bronchospasm", "Chronic Obstructive Pulmonary Disease (COPD)" ], "interventions": [ { "name": "A006", "type": "DRUG" }, { "name": "Placebo DPI", "type": "DRUG" }, { "name": "Proventil-HFA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amphastar Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 27, "start_date": "2010-07", "completion_date": "2011-01", "has_results": false, "last_update_posted_date": "2017-07-02", "last_synced_at": "2026-10-07T11:27:47.840Z", "location_count": 4, "location_summary": "Medford, Oregon • Portland, Oregon • San Antonio, Texas + 1 more", "locations": [ { "city": "Medford", "state": "Oregon" }, { "city": "Portland", "state": "Oregon" }, { "city": "San Antonio", "state": "Texas" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01189396" } ] }